Clinical trial
Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)
NCT06083454
Study timeline
Study start (actual)2023-10-23Date precision: day
Registry last updated2026-03-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small Cell Lung Cancerunresolved
Interventions
Sponsors & collaborators
William Zeitlerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06083454 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.